GlassScriptPhysician profile
Kendra B Meche
NPI 1326295239
$6,232.51
in general payments reported to CMS, 2019-2025
38 companies · $937 in 2025
The $937 reported for 2025 was more than what 83% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,497 · 2022: $1,371 · 2023: $905 · 2024: $1,523 · 2025: $937.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,364.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,217.17 | 2021-2025 | |
| Novo Nordisk INC | $700.81 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Amgen INC. | $561.13 | 2021-2025 | Evenity, Prolia, Repatha |
| Glaxosmithkline, LLC. | $512.57 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $491.47 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $427.80 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Novartis Pharmaceuticals Corporation | $247.47 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $211.74 | 2023-2025 | Gemtesa |
| Amarin Pharma, INC. | $191.87 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $173.65 | 2021-2024 | Jardiance, Ofev |
| Merck Sharp & Dohme LLC | $165.26 | 2021-2025 | Gardasil 9, Capvaxive, Gardasil |
| Exact Sciences Corporation | $153.61 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $148.94 | 2022-2024 | |
| Pfizer INC. | $143.33 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $93.23 | 2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendra Meche listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.